Regeneron Pharmaceuticals Market Cap

Regeneron Pharmaceuticals has a market cap or net worth of €49.69 billion as of September 30, 2025. Its market cap has decreased by -55.74% in one year.

Market Cap

49.69B

Enterprise Value

37.06B

Revenue

12.10B

Ranking

n/a

PE Ratio

13.09

Stock Price

€480.30

Market Cap Chart

Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 131.41M to 49.69B, an increase of 37,712.25%. That is a compound annual growth rate of 19.56%.

Market Cap History

Date	Market Cap	% Change
Sep 30, 2025	49.69B	-32.88%
Dec 31, 2024	74.03B	-12.40%
Dec 29, 2023	84.50B	17.20%
Dec 30, 2022	72.10B	24.19%
Dec 31, 2021	58.06B	39.28%
Dec 31, 2020	41.68B	13.96%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	265.41B
Siemens Aktiengesellschaft	175.44B
Deutsche Telekom AG	137.39B
Allianz SE	135.64B
Rheinmetall AG	91.23B
Siemens Energy AG	84.43B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	70.31B
Deutsche Bank Aktiengesellschaft	57.48B

Market Cap Rankings